Dr.
Huynh Minh Tuan
Head, Microbiology Department and Infection Control Department at the University Medical Center Ho Chi Minh City, Vietnam
Title of the talk: Susceptibility of Enterobacterales to ceftazidime-avibactam at University Medical Center Ho Chi Minh City
Abstract
Background: Ceftazidime-avibactam is a new generation β-lactam/β-lactamase inhibitor combination antibiotic recommended for the treatment of serious infections caused by multidrug-resistant bacteria. In Vietnam, this antibiotic has only recently been introduced, so there are few reports on its susceptibility. Objectives: To determine the susceptibility of Enterobacterales to ceftazidime-avibactam at University Medical Center Ho Chi Minh City. Methods: Enterobacterales isolated from clinical specimens at University Medical Center Ho Chi Minh City from February 2023 to January 2024 were identified using the BD Phoenix M50 (Becton Dickinson, USA) and Vitek 2 Compact (Bio-Mérieux, France) automated identification systems. The MICs of antibiotics were determined using the NMIC500 CPO automated kit on the BD Phoenix M50 system (Becton Dickinson, USA). Susceptibility to antibiotics was interpreted according to CLSI 2023 criteria. Results: Among 1961 isolates of Enterobacterales from patients with respiratory infections, bacteremia, urinary tract infections, skin and soft tissue infections, abdominal infections, and other infections, E. coli and K. pneumoniae were the two leading pathogens with rates of 39% and 37%, respectively. The susceptibility rate of Enterobacterales to ceftazidime-avibactam was 85.2%, and the susceptibility rate of carbapenem-resistant Enterobacterales (CRE) was 45.3%. The susceptibility rate of ceftazidime-avibactam for E. coli was 96.3%, and that for carbapenem-resistant E. coli was 68.3%. The susceptibility rate of ceftazidime-avibactam for K. pneumoniae was 72.0%, and that for carbapenem-resistant K. pneumoniae was 41.4%. The susceptibility rate of ceftazidime-avibactam for S. marcescens was 58.2%, and that for carbapenem-resistant S. marcescens was 31.7%. Conclusion: The susceptibility of Enterobacterales to ceftazidime-avibactam remains high, but is significantly reduced in carbapenem-resistant Enterobacterales.
Biography
Huynh Minh Tuan has completed his MSc from the University of Arkansas, USA, and his PhD from the University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam. He is the head of the Microbiology Department and Infection Control Department at the University Medical Center Ho Chi Minh City, a teaching hospital of the University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam. He has published more than 30 papers in domestic and international journals and has been serving as a lecturer in medical microbiology and infection control for over 20 years.
Publications: ORCID